Dialysis Clinical Trials in Shanghai, Shanghai Municipality
8 recruitingShanghai, Shanghai Municipality, China
Showing 1–8 of 8 trials
Recruiting
Phase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
End Stage Renal Disease on DialysisHyperphosphatemiaChronic Kidney Disease Requiring Chronic Dialysis
R1 Therapeutics168 enrolled26 locationsNCT06712654
Recruiting
Phase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
HyperphosphatemiaDialysisChronic Kidney Disease, Receiving Dialysis+1 more
Alebund Pharmaceuticals264 enrolled42 locationsNCT06933472
Recruiting
Effects of pHA Hemoperfusion Plus Hemodialysis on Protein-Bound Uremic Toxins
End Stage Renal Disease on Dialysis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine120 enrolled1 locationNCT07016841
Recruiting
DRug-coAted Balloon Compared With cuttinG balloON in Treatment of Arteriovenous Fistula Stenosis
Arteriovenous FistulaHemodialysis Access FailureAngioplasty, Balloon
RenJi Hospital180 enrolled3 locationsNCT06527963
Recruiting
Effectiveness of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure
Hemodialysis Access Failure
RenJi Hospital180 enrolled3 locationsNCT06493292
Recruiting
Effectiveness and Health Economics of Endoluminal Treatment of Arteriovenous Graft Fistula.
Hemodialysis Access Failure
RenJi Hospital240 enrolled1 locationNCT06470646
Recruiting
Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure
Hemodialysis Access Failure
RenJi Hospital480 enrolled1 locationNCT06454396
Recruiting
Toxicokinetics of Protein-bound Uremic Toxins in ESRD Patients
Renal DialysisUremic; ToxemiaPharmacokinetics
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University100 enrolled1 locationNCT05755503